search
menu
Company
About NIOX Group plc
Company profile
Board of directors
Company scientific advisor
Management team
Corporate responsibility
Products
Our products
Product contacts
Investors
Investor centre
Company profile
Regulatory news
Share price chart
Share price summary
Financial reports
Financial calendar
Registrars
AIM rule 26
Analyst coverage
Email alerts
Investor contacts
Investor presentations
Shareholder Documents
Media
Press releases
Company profile
Media contacts
Careers
Global opportunities
Job Applicant Privacy Notice
Contacts
Locations
Product contacts
Investor contacts
Media contacts
Career Contacts
search
House dust mite SPIRE
Larche, et al. J Allergy Clin Immunol. Volume 131, Number 2. Safety and Tolerability of Escalating Doses of House Dust Mite- Peptide Antigen Desensitization (HDM-PAD) [PDF]
Download PDF
close
search
